CB Richard Ellis's The Pharamaceutical Sector: Real Estate Implications of Industry-Wide Change

"CBRE’s survey of key industry decision makers demonstrates that the top ten global pharmaceutical (pharma) companies occupy at least 430m sq ft of office, manufacturing and specialist research space around the world, of which approximately 75% is owned - one of the highest ownership ratios of any corporate sector."

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article

Registration includes the following benefits:

  • Access up to four FREE articles per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.

Registered users and subscribers SIGN IN here to continue